ONCT logo

Oncternal Therapeutics (ONCT) Net Income

Annual Net Income

-$39.48 M
+$4.69 M+10.62%

December 31, 2023

Summary

Performance

1-Year Change

+10.62%

3-Year Change

-129.2%

5-Year Change

-2.76%

15-Year Change

-29.7%

ONCT Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

42.86%
ONCT annual net profit is higher than 42.86% of companies in Healthcare sector

High & Low

All-time High

$15.29 M
ONCT annual net profit is currently -358.13% below its historical high of $15.29 million

3-Year Low

-$44.17 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ONCT previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 7, 2025
ONCT next annual earnings announcement is scheduled for Mar 7, 2025

OtherONCTprofitabilitymetrics:

Annual Net Margin

-
ONCT annual net profit margin value is unknown

Annual Revenue

-
ONCT annual revenue value is unknown

Annual Gross Profit

-
ONCT annual gross profit value is unknown

Annual EPS

-$13.43
ONCT annual earnings per share is -$13.43

Quarterly Net Income

-$8.46 M
+$95.00 K+1.11%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+26.32%

5-Year Change

+26.32%

ONCT Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

44.4%
ONCT quarterly net profit is higher than 44.4% of companies in Healthcare sector

High & Low

All-time High

$44.34 M
ONCT quarterly net profit is currently -119.09% below its historical high of $44.34 million

3-Year Low

-$11.74 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ONCT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
ONCT next earnings announcement is scheduled for Mar 7, 2025

OtherONCTprofitabilitymetrics:

Quarterly Net Margin

-
ONCT quarterly net profit margin value is unknown

Quarterly Revenue

-
ONCT quarterly revenue value is unknown

Quarterly Gross Profit

-
ONCT quarterly gross profit value is unknown

Quarterly EPS

-$2.86
ONCT quarterly earnings per share is -$2.86

TTM Net Income

-$34.58 M
+$1.40 M+3.89%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+24.43%

5-Year Change

+24.43%

ONCT TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

45.49%
ONCT TTM net profit is higher than 45.49% of companies in Healthcare sector

High & Low

All-time High

$27.69 M
ONCT TTM net profit is currently -224.88% below its historical high of $27.69 million

3-Year Low

-$45.75 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ONCT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
ONCT next earnings announcement is scheduled for Mar 7, 2025

OtherONCTprofitabilitymetrics:

Annual Net Margin

-
ONCT annual net profit margin value is unknown

TTM Revenue

-
ONCT TTM revenue value is unknown

TTM Gross Profit

-
ONCT TTM gross profit value is unknown

TTM EPS

-$11.69
ONCT TTM earnings per share is -$11.69

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$39.48 M
ONCT annual net profit is -$39.48 million

Annual Revenue

-
ONCT annual revenue value is unknown

Annual Cost Of Goods Sold

-
ONCT annual cost of goods sold value is unknown

Annual Operating Expenses

$41.71 M
ONCT annual total operating expenses is $41.71 million

Annual Interest Expense

-
ONCT annual interest expense value is unknown

Annual Income Tax

-
ONCT annual income tax value is unknown

ONCT Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+10.6%0.0%0.0%
3 y3 years-129.2%+26.3%+24.4%
5 y5 years-2.8%+26.3%+24.4%

ONCT Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-26.0%+10.6%-4.8%+27.9%-10.3%+24.4%
5 y5-year-129.2%+10.6%-231.0%+27.9%-100.7%+24.4%
alltimeall time-358.1%+23.8%-119.1%+82.3%-224.9%+50.5%

Oncternal Therapeutics Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$8.46 M(-1.1%)
-$34.58 M(-3.9%)
Jun 2024
-
-$8.56 M(+2.0%)
-$35.97 M(-1.1%)
Mar 2024
-
-$8.39 M(-8.5%)
-$36.38 M(-7.8%)
Dec 2023
-$39.48 M(-10.6%)
-$9.16 M(-7.1%)
-$39.48 M(-5.4%)
Sep 2023
-
-$9.86 M(+10.0%)
-$41.72 M(-2.9%)
Jun 2023
-
-$8.97 M(-21.9%)
-$42.98 M(-6.1%)
Mar 2023
-
-$11.49 M(+0.8%)
-$45.75 M(+3.6%)
Dec 2022
-$44.17 M(+41.0%)
-$11.40 M(+2.5%)
-$44.17 M(+8.1%)
Sep 2022
-
-$11.13 M(-5.2%)
-$40.84 M(+3.8%)
Jun 2022
-
-$11.74 M(+18.5%)
-$39.35 M(+11.5%)
Mar 2022
-
-$9.90 M(+22.7%)
-$35.29 M(+12.6%)
Dec 2021
-$31.33 M(+81.9%)
-$8.07 M(-16.2%)
-$31.33 M(+21.4%)
Sep 2021
-
-$9.63 M(+25.4%)
-$25.82 M(+25.4%)
Jun 2021
-
-$7.68 M(+29.2%)
-$20.58 M(+11.6%)
Mar 2021
-
-$5.95 M(+132.6%)
-$18.43 M(+7.0%)
Dec 2020
-$17.23 M(-49.6%)
-$2.56 M(-41.8%)
-$17.23 M(-8.5%)
Sep 2020
-
-$4.39 M(-20.6%)
-$18.82 M(-2.6%)
Jun 2020
-
-$5.54 M(+16.8%)
-$19.32 M(-47.3%)
Mar 2020
-
-$4.74 M(+14.0%)
-$36.63 M(-2.8%)
Dec 2019
-$34.19 M(-11.0%)
-$4.16 M(-15.0%)
-$37.70 M(-3.2%)
Sep 2019
-
-$4.89 M(-78.6%)
-$38.95 M(-10.4%)
Jun 2019
-
-$22.85 M(+293.8%)
-$43.49 M(+41.8%)
Mar 2019
-
-$5.80 M(+7.1%)
-$30.66 M(-20.2%)
Dec 2018
-$38.42 M(+26.2%)
-$5.42 M(-42.6%)
-$38.42 M(-9.1%)
Sep 2018
-
-$9.43 M(-5.8%)
-$42.28 M(+2.2%)
Jun 2018
-
-$10.02 M(-26.1%)
-$41.35 M(+9.6%)
Mar 2018
-
-$13.56 M(+46.1%)
-$37.74 M(+24.0%)
Dec 2017
-$30.44 M(+71.7%)
-$9.28 M(+9.1%)
-$30.44 M(+8.6%)
Sep 2017
-
-$8.50 M(+32.8%)
-$28.03 M(+6.0%)
Jun 2017
-
-$6.41 M(+2.4%)
-$26.44 M(+1.4%)
Mar 2017
-
-$6.25 M(-8.9%)
-$26.08 M(+47.2%)
Dec 2016
-$17.72 M(-5.2%)
-$6.86 M(-0.7%)
-$17.72 M(+25.8%)
Sep 2016
-
-$6.91 M(+14.2%)
-$14.09 M(-150.9%)
Jun 2016
-
-$6.05 M(-387.4%)
$27.69 M(-294.8%)
Mar 2016
-
$2.11 M(-165.1%)
-$14.21 M(-24.0%)
Dec 2015
-$18.70 M(-52.5%)
-$3.23 M(-109.3%)
-$18.70 M(-37.7%)
Sep 2015
-
$34.87 M(-172.7%)
-$30.02 M(-57.0%)
Jun 2015
-
-$47.95 M(+1911.4%)
-$69.82 M(+112.8%)
Mar 2015
-
-$2.38 M(-83.6%)
-$32.81 M(-16.8%)
Dec 2014
-$39.41 M(-6.4%)
-$14.54 M(+194.7%)
-$39.41 M(+20.7%)
Sep 2014
-
-$4.93 M(-54.9%)
-$32.66 M(-10.9%)
Jun 2014
-
-$10.94 M(+21.8%)
-$36.66 M(-4.8%)
Mar 2014
-
-$8.99 M(+15.4%)
-$38.52 M(-8.5%)
Dec 2013
-$42.11 M
-$7.79 M(-12.8%)
-$42.11 M(-6.5%)
Sep 2013
-
-$8.94 M(-30.2%)
-$45.04 M(+45.3%)
DateAnnualQuarterlyTTM
Jun 2013
-
-$12.80 M(+1.7%)
-$31.00 M(+8.5%)
Mar 2013
-
-$12.58 M(+17.4%)
-$28.58 M(+5.5%)
Dec 2012
-$27.07 M(-18.7%)
-$10.71 M(-310.1%)
-$27.07 M(+0.1%)
Sep 2012
-
$5.10 M(-149.1%)
-$27.04 M(-34.8%)
Jun 2012
-
-$10.38 M(-6.3%)
-$41.49 M(-0.7%)
Mar 2012
-
-$11.08 M(+3.7%)
-$41.78 M(+25.5%)
Dec 2011
-$33.29 M(-317.7%)
-$10.68 M(+14.3%)
-$33.29 M(+10.5%)
Sep 2011
-
-$9.34 M(-12.5%)
-$30.14 M(+2.6%)
Jun 2011
-
-$10.67 M(+311.3%)
-$29.37 M(-7.2%)
Mar 2011
-
-$2.60 M(-65.5%)
-$31.64 M(-306.9%)
Dec 2010
$15.29 M(-133.1%)
-$7.53 M(-12.2%)
$15.29 M(+28.0%)
Sep 2010
-
-$8.57 M(-33.7%)
$11.95 M(+55.1%)
Jun 2010
-
-$12.94 M(-129.2%)
$7.70 M(-17.9%)
Mar 2010
-
$44.34 M(-507.7%)
$9.38 M(-120.3%)
Dec 2009
-$46.26 M(-10.7%)
-$10.88 M(-15.2%)
-$46.26 M(-6.1%)
Sep 2009
-
-$12.82 M(+13.9%)
-$49.25 M(+1.8%)
Jun 2009
-
-$11.26 M(-0.4%)
-$48.35 M(-3.9%)
Mar 2009
-
-$11.30 M(-18.5%)
-$50.34 M(-2.8%)
Dec 2008
-$51.78 M(+28.3%)
-$13.87 M(+16.3%)
-$51.78 M(+2.1%)
Sep 2008
-
-$11.93 M(-9.9%)
-$50.70 M(+3.4%)
Jun 2008
-
-$13.24 M(+3.9%)
-$49.02 M(+9.0%)
Mar 2008
-
-$12.74 M(-0.4%)
-$44.98 M(+11.4%)
Dec 2007
-$40.36 M(+13.7%)
-$12.79 M(+24.9%)
-$40.36 M(+25.0%)
Sep 2007
-
-$10.24 M(+11.3%)
-$32.28 M(-2.0%)
Jun 2007
-
-$9.20 M(+13.3%)
-$32.93 M(-2.3%)
Mar 2007
-
-$8.12 M(+72.4%)
-$33.71 M(-5.1%)
Dec 2006
-$35.51 M(-3.6%)
-$4.71 M(-56.7%)
-$35.51 M(-8.0%)
Sep 2006
-
-$10.89 M(+9.1%)
-$38.59 M(+2.5%)
Jun 2006
-
-$9.98 M(+0.6%)
-$37.65 M(-0.1%)
Mar 2006
-
-$9.92 M(+27.3%)
-$37.68 M(+2.3%)
Dec 2005
-$36.84 M(+64.8%)
-$7.80 M(-21.6%)
-$36.84 M(+2.5%)
Sep 2005
-
-$9.94 M(-0.8%)
-$35.93 M(+15.5%)
Jun 2005
-
-$10.02 M(+10.4%)
-$31.11 M(+21.5%)
Mar 2005
-
-$9.08 M(+31.9%)
-$25.61 M(+14.6%)
Dec 2004
-$22.35 M(+57.4%)
-$6.88 M(+34.3%)
-$22.35 M(+11.7%)
Sep 2004
-
-$5.13 M(+13.4%)
-$20.01 M(+9.4%)
Jun 2004
-
-$4.52 M(-22.4%)
-$18.29 M(+6.1%)
Mar 2004
-
-$5.82 M(+28.0%)
-$17.23 M(+21.4%)
Dec 2003
-$14.19 M(+19.6%)
-$4.55 M(+33.7%)
-$14.19 M(+47.1%)
Sep 2003
-
-$3.40 M(-1.8%)
-$9.65 M(+54.5%)
Jun 2003
-
-$3.46 M(+24.6%)
-$6.25 M(+124.6%)
Mar 2003
-
-$2.78 M
-$2.78 M
Dec 2002
-$11.87 M(+47.2%)
-
-
Dec 2001
-$8.06 M(+111.5%)
-
-
Dec 2000
-$3.81 M(+408.3%)
-
-
Dec 1999
-$750.00 K
-
-

FAQ

  • What is Oncternal Therapeutics annual net profit?
  • What is the all time high annual net income for Oncternal Therapeutics?
  • What is Oncternal Therapeutics annual net income year-on-year change?
  • What is Oncternal Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Oncternal Therapeutics?
  • What is Oncternal Therapeutics quarterly net income year-on-year change?
  • What is Oncternal Therapeutics TTM net profit?
  • What is the all time high TTM net income for Oncternal Therapeutics?
  • What is Oncternal Therapeutics TTM net income year-on-year change?

What is Oncternal Therapeutics annual net profit?

The current annual net income of ONCT is -$39.48 M

What is the all time high annual net income for Oncternal Therapeutics?

Oncternal Therapeutics all-time high annual net profit is $15.29 M

What is Oncternal Therapeutics annual net income year-on-year change?

Over the past year, ONCT annual net profit has changed by +$4.69 M (+10.62%)

What is Oncternal Therapeutics quarterly net profit?

The current quarterly net income of ONCT is -$8.46 M

What is the all time high quarterly net income for Oncternal Therapeutics?

Oncternal Therapeutics all-time high quarterly net profit is $44.34 M

What is Oncternal Therapeutics quarterly net income year-on-year change?

Over the past year, ONCT quarterly net profit has changed by $0.00 (0.00%)

What is Oncternal Therapeutics TTM net profit?

The current TTM net income of ONCT is -$34.58 M

What is the all time high TTM net income for Oncternal Therapeutics?

Oncternal Therapeutics all-time high TTM net profit is $27.69 M

What is Oncternal Therapeutics TTM net income year-on-year change?

Over the past year, ONCT TTM net profit has changed by $0.00 (0.00%)